Sale!

CWF19L1 Gene Spinocerebellar Ataxia Type 17 Autosomal Recessive NGS Genetic DNA Test

Original price was: KSh 56,000.Current price is: KSh 40,000.

-29%

The CWF19L1 Gene Spinocerebellar Ataxia Type 17 Autosomal Recessive NGS Genetic DNA Test is a specialized genetic test designed to detect mutations associated with Spinocerebellar Ataxia Type 17. This test is crucial for individuals with a family history of neurological disorders, providing insights into potential genetic risks. Priced at KSh 40,000, it offers valuable information for proactive health management.

Book your test online and get free home sample collection

  • 100% Accurate Test Results
  • Get Tested at Kenya No1 Genetic DNA Lab
  • Customer support Call 0713408028
Guaranteed Safe Checkout

CWF19L1 Gene Spinocerebellar Ataxia Type 17 Autosomal Recessive NGS Genetic DNA Test

Introduction

The CWF19L1 Gene Spinocerebellar Ataxia Type 17 Autosomal Recessive NGS Genetic DNA Test is a cutting-edge genetic test that employs Next Generation Sequencing (NGS) technology to analyze the CWF19L1 gene. This test is essential for diagnosing Spinocerebellar Ataxia Type 17, a hereditary neurological disorder characterized by progressive loss of coordination and balance. Understanding your genetic predisposition can lead to early intervention and better management of symptoms.

What the Test Measures

This test specifically detects mutations in the CWF19L1 gene, which are linked to Spinocerebellar Ataxia Type 17. By identifying these mutations, healthcare providers can assess the risk of developing this condition and offer tailored management strategies.

Who Should Consider This Test

Individuals who have a family history of neurological disorders, particularly those exhibiting symptoms such as:

  • Unexplained balance issues
  • Coordination difficulties
  • Changes in speech or swallowing

should consider this test. Additionally, those with risk factors such as a known family history of Spinocerebellar Ataxia should seek testing for better health insights.

Benefits of Taking the Test

  • Early detection of genetic predispositions to neurological disorders.
  • Informed decision-making regarding health management and lifestyle choices.
  • Access to genetic counseling for affected family members.
  • Proactive management of symptoms and potential interventions.

Understanding Your Results

Results from the CWF19L1 Gene Spinocerebellar Ataxia Type 17 test typically take about 3 to 4 weeks to process. A positive result indicates the presence of mutations associated with the disorder, while a negative result suggests no known mutations were detected. It is important to discuss your results with a healthcare provider for proper interpretation and guidance.

Test Pricing

Price Type Amount (KSh)
Discount Price 40,000
Regular Price 56,000

Book Your Test Today!

We have branches across Kenya and offer home sample collection services. Don’t wait to take control of your health. Book the CWF19L1 Gene Spinocerebellar Ataxia Type 17 Autosomal Recessive NGS Genetic DNA Test today! For more information or to schedule your appointment, call or WhatsApp us at +254713408028.